Ring Christine bought NRIX
January 20, 2026 · Form 4 insider transaction
Ring Christine bought 3,760 shares of Nurix Therapeutics, Inc. at $1.86 per share, a transaction worth $7.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,760
Price
$1.86
Total value
$7.0K
InsiderRing Christine
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 20, 2026
Filing dateJanuary 20, 2026
Shares owned after54,657
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.